This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
Paul de Kruif's enthusiastic article in this month's Reader's Digest entitled "Hope for the Victims of Arthritis" might better have been called "False Hope for the Victims of Arthritis."Since its publication I have had many inquiries from all parts of the United States both from physicians and from patients with arthritis. Dr. de Kruif's paper concerns Ertron, a vitamin D preparation manufactured by the Nutrition Research Laboratories, Chicago, and reviews a report of Dr. R. Garfield Snyder, who for the past six years has conducted a study of this in various forms of arthritis.The objection which I have to the article in the Reader's Digest is that it stimulates great hope in the minds of patients with arthritis for a therapeutic agent of uncertain, if of any, permanent value, which is quite expensive, and the manufacturers of which have carried on a most intensive advertising
Boots RH. "HOPE (FALSE) FOR THE VICTIMS OF ARTHRITIS". JAMA. 1943;123(13):857. doi:10.1001/jama.1943.02840480057022
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: